D. E. Shaw & Co. Inc. Makes New $49,000 Investment in Inozyme Pharma, Inc. (NASDAQ:INZY)
D. E. Shaw & Co. Inc. bought a new position in shares of Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 17,813 shares of the company’s stock, valued at approximately $49,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes […]
D. E. Shaw & Co. Inc. bought a new position in shares of Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 17,813 shares of the company’s stock, valued at approximately $49,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes […]
